JONGOH KIM
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism SUGAR LAND, TX NPI 1114181591
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism TX SANOFI-AVENTIS U.S. LLC All categories
General Payments — all program years on this page
$6,377.88
- Category: General Payments
- Program years: PY2018–2024
- Record count: 307
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,488.55 across 120 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,488.55 | 120 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $269.89 | 11 |
| Abbott Laboratories | $227.47 | 12 |
| Insulet Corporation | $214.08 | 8 |
| Lilly USA, LLC | $178.55 | 9 |
| Novo Nordisk AS | $173.83 | 8 |
| Amgen Inc. | $167.67 | 10 |
| Corcept Therapeutics | $150.76 | 8 |
| RECORDATI_RARE_DISEASES_INC. | $116.25 | 5 |
| Radius Health, Inc. | $109.72 | 5 |
| ABBVIE INC. | $89.94 | 4 |
| Xeris Pharmaceuticals, Inc. | $85.29 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $84.39 | 5 |
| BETA BIONICS, INC. | $82.52 | 5 |
| Tandem Diabetes Care, Inc. | $79.43 | 4 |
| DEXCOM, INC. | $70.33 | 3 |
| Embecta Corp. | $60.56 | 4 |
| Bayer HealthCare Pharmaceuticals Inc. | $58.26 | 3 |
| Kyowa Kirin, Inc. | $46.75 | 2 |
| Amneal Pharmaceuticals LLC | $40.36 | 2 |
| Medtronic, Inc. | $37.37 | 1 |
| CeQur Corporation | $34.70 | 1 |
| Acerta Pharma LLC | $34.06 | 2 |
| TheracosBio, LLC | $22.63 | 1 |
| PFIZER INC. | $19.54 | 1 |
| Ultragenyx Pharmaceutical Inc. | $19.24 | 1 |
| IBSA Pharma Inc. | $14.96 | 1 |
By program year
Records — PY2024 (120)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.